Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 81 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 7906513

    Hydrazide-containing hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted
  2. US 7906530

    1,7-naphthyridine derivatives as p38 MAP kinase inhibitors

    Laboratories Almirall, S.A. · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted
  3. US 7906550

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted
  4. US 7902166

    Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same

    The Board of Regents of the University of Oklahoma · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted
  5. US 7902239

    Diaminotriazoles useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted
  6. US 7884119

    Triazole derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted
  7. US 7883881

    Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes

    Vertex Pharmaceuticals Incorporated · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted
  8. US 7879792

    Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted
  9. US 7879856

    Diaminothiazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted
  10. US 7875712

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted
  11. US 7872031

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  12. US 7872129

    Compositions useful as inhibitors of GSK-3

    Vertex Pharmaceuticals Incorporated · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  13. US 7872000

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  14. US 7872124

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  15. US 7862815

    Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  16. US 7863282

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  17. US 7855214

    Fused cyclic systems useful as inhibitors of TEC family protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  18. US 7850970

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of bacterial infections

    The Regents of the University of Colorado · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  19. US 7851495

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  20. US 7846945

    Piperdine-based inhibitors of sodium glucose co-transporter 2 and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  21. US 7838517

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted
  22. US 7838531

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted
  23. US 7834037

    5-lipoxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted
  24. US 7829561

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted